Therefore, topical ISC-4 offers potential to hold off or slower melanocytic lesion or melanoma advancement in preclinical versions and may impact melanoma incidence if identical results are seen in humans
Therefore, topical ISC-4 offers potential to hold off or slower melanocytic lesion or melanoma advancement in preclinical versions and may impact melanoma incidence if identical results are seen in humans.…